The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAvingtrans Regulatory News (AVG)

Share Price Information for Avingtrans (AVG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 415.00
Bid: 410.00
Ask: 420.00
Change: 0.00 (0.00%)
Spread: 10.00 (2.439%)
Open: 415.00
High: 415.00
Low: 415.00
Prev. Close: 415.00
AVG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Share Incentive Awards, Issue of Equity and TVR

16 Nov 2018 09:30

RNS Number : 6010H
Avingtrans PLC
16 November 2018
 

Avingtrans Plc

 

("Avingtrans" or the "Company" or the "Group")

 

Share Incentive Awards, Issue of Equity and TVR

 

Avingtrans plc announces that the Company has under the terms of the Company's Executive Shared Ownership Plan (the "ExSOP") and CSOP share scheme (the "CSOP") made grants of awards over ordinary shares of 5p each in the Company ("Ordinary Shares") as set out below.

 

Awards under the ExSOP

 

On 15 November 2018, the Board of Avingtrans, in accordance with the Company's ExSOP, granted awards over 285,000 Ordinary Shares at an option price of 220p. The following ExSOP awards were granted to Directors and a PDMR, with each paying 0.1 pence for his interest in each Ordinary Share subject to his ExSOP award:

 

Director

Number of Ordinary Shares subject to ExSOP awards

Steve McQuillan

115,000

Stephen King

100,000

 

Furthermore Austen Adams, Managing Director of the Group's PSRE Division and a PDMR of the Company, has been granted ExSOP awards over a total of 70,000 Ordinary Shares.

 

Under the provisions of the ExSOP, Ordinary Shares are jointly owned between the individuals above and by an employees' share trust, on terms, similar to a share option scheme, whereby the participant can benefit only from the future growth in the value of the Ordinary Shares above the closing market value of the shares on the award date (being therefore the closing market value on 15 November 2018) in excess of a carrying cost. 

 

Awards are subject to a performance condition and participants may not normally realise any such benefit before 15 November 2021. The performance condition for each of the ExSOP awards is that the increase in adjusted EPS must be at least equal to the increase in RPI over the vesting period.

 

The awards under the ExSOP have been satisfied through the issue of 285,000 new Ordinary Shares. Application has been made for admission to trading on AIM for the 285,000 new Ordinary Shares ("Admission"). It is expected that Admission will be effective on 22 November 2018.

 

Subsequent to the issue of the new Ordinary Shares as above, the Company's total issued share capital is 31,362,053 Ordinary Shares. Avingtrans does not hold any Ordinary Shares in treasury. Therefore, the total number of voting rights in Avingtrans is 31,362,053.

 

Awards under the CSOP

 

On 15 November 2018, the Board of Avingtrans, in accordance with the Company's CSOP, granted options over 205,000 Ordinary Shares with an option price of 218.5 pence per Ordinary Share.

 

All of the options granted may not be exercised until 3 years from the date of grant and are subject to a performance condition. The performance condition for each of these options is that the increase in adjusted EPS must be at least equal to the increase in RPI over the vesting period.

 

Enquiries:

Avingtrans plc

01354 692391

Roger McDowell, Chairman

Steve McQuillan, Chief Executive Officer

Stephen King, Chief Financial Officer

N+1 Singer (Nominated Adviser)

02074 963000

Shaun Dobson

Lauren Kettle

Newgate (Financial PR)

02076 539850

Adam Lloyd

Tom Carnegie

 

About Avingtrans:

Avingtrans is engaged in the provision of highly engineered components, systems and services to the energy, medical and traffic management industries worldwide.

Energy and Medical

Stainless Metalcraft Ltd - Chatteris, UK and Chengdu, China

Provider of safety-critical equipment for the energy, medical, science and research communities, worldwide, specialising in precision pressure and vacuum vessels and associated fabrications, sub-assemblies and systems.

Maloney Metalcraft Ltd - Aldridge, UK

Designs, manufactures and services oil and gas extraction and processing equipment, including process plant for dehydration, sweetening, drying and compression.

Hayward Tyler - Luton & East Kilbride, UK and USA, China and India

Specialises in the design, manufacture and servicing of performance-critical motors and pumps in challenging environments

Peter Brotherhood - Peterborough, UK

Specialises in the design, manufacture and servicing of performance-critical steam turbines, turbo gen-sets, compressors, gear boxes and combined heat and power systems

Composite Products Ltd - Buckingham, UK

Centre for composite technology, parts and assemblies, serving customers in industrial markets.

Scientific Magnetics - Abingdon, UK

Designs and manufactures superconducting magnet systems and associated cryogenic systems for a variety of markets

Crown International Ltd - Portishead, UK

Designs and manufactures market-leading pole and support systems for roadside signage and safety cameras, rail track signalling and gantries.

 

EU Market Abuse Regulation

The notifications set out below are provided in accordance with the requirements of the EU Market Abuse Regulation.

 

1

Details of the person discharging managerial responsibilities / person closely associated

 

a)

Name 

Steve McQuillan

 

2

Reason for the notification

 

a)

Position/status

CEO 

 

b)

 

Initial notification /Amendment

Initial

 

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

Name

Avingtrans plc 

 

b)

LEI

213800ZZ96CKPI423E86

 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Ordinary shares of 5p each in the Company awarded under the ExSOP share scheme

 

Identification Code

GB0009188797

 

b)

Nature of the transaction

Share award

 

 

c)

Price(s) and volume(s)

 

 

Price(s)

 

Volume(s)

0.1p

 

115,000

 

d)

Aggregated information

 

- Aggregated volume

 

- Price

 

 

n/a - single transaction

e)

Date of the transaction

15 November 2018

 

 

f)

Place of the transaction

London Stock Exchange 

 

 

1

Details of the person discharging managerial responsibilities / person closely associated

 

a)

Name 

Stephen King

 

2

Reason for the notification

 

a)

Position/status

CFO 

 

b)

 

Initial notification /Amendment

Initial

 

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

Name

Avingtrans plc 

 

b)

LEI

213800ZZ96CKPI423E86

 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Ordinary shares of 5p each in the Company awarded under the ExSOP share scheme

 

Identification Code

GB0009188797

 

b)

Nature of the transaction

Share award

 

 

c)

Price(s) and volume(s)

 

 

Price(s)

 

Volume(s)

0.1p

 

100,000

 

d)

Aggregated information

 

- Aggregated volume

 

- Price

 

 

n/a - single transaction

e)

Date of the transaction

15 November 2018

 

 

f)

Place of the transaction

London Stock Exchange 

 

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name 

Austen Adams

 

2

Reason for the notification

 

a)

Position/status

Managing Director, PSRE Division

b)

 

Initial notification /Amendment

Initial

 

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

Name

Avingtrans plc 

 

b)

LEI

213800ZZ96CKPI423E86

 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Ordinary shares of 5p each in the Company awarded under the ExSOP share scheme

 

 

Identification Code

GB0009188797

 

b)

Nature of the transaction

Share award

 

 

c)

Price(s) and volume(s)

 

 

Price(s)

 

Volume(s)

Nil

 

70,000

 

d)

Aggregated information

 

- Aggregated volume

 

- Price

 

 

n/a - single transaction

 

e)

Date of the transaction

15 November 2018

 

 

f)

Place of the transaction

London Stock Exchange 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IOEUNRKRWWAAARA
Date   Source Headline
26th Mar 202411:15 amRNSPDMR Dealings
21st Mar 20245:15 pmRNSExercise of Options, PDMR Dealings & TVR
20th Mar 20243:39 pmRNSHolding(s) in Company
4th Mar 20246:10 pmRNSPDMR Dealings
28th Feb 20247:00 amRNSInterim Results
18th Jan 20247:00 amRNSTrading Update and Notice of Results
15th Dec 20233:00 pmRNSExercise of Options & TVR
4th Dec 20237:00 amRNSMagnetica Limited appoints US distributor
22nd Nov 20237:00 amRNSEmployee & PDMR Share Incentive Awards
16th Nov 20232:20 pmRNSResult of AGM
13th Nov 20237:00 amRNSHayward Tyler Contract Win
11th Oct 20237:00 amRNSContract Wins
28th Sep 20235:54 pmRNSHolding(s) in Company
27th Sep 20237:00 amRNSPreliminary results for the year ended 31 May 2023
25th Sep 20237:00 amRNSHolding(s) in Company
18th Sep 20237:00 amRNSCompletion of Acquisition of Adaptix Ltd
4th Sep 20237:00 amRNSBoard Update
7th Aug 20237:00 amRNSAcquisition of Slack & Parr and Adaptix update
13th Jul 20237:00 amRNSTrading Update & Possible Acquisition of Adaptix
5th Jun 20237:00 amRNSBoard Changes
22nd Feb 20237:00 amRNSInterim Results
15th Feb 20237:00 amRNSAdaptix appoints Willem Baralt as new Chairman
30th Jan 20237:00 amRNSAdaptix secures 510(k) clearance from FDA
27th Jan 20231:19 pmRNSEmployee & PDMR Share Incentive Awards
23rd Jan 20236:12 pmRNSPDMR Dealings
18th Jan 20237:00 amRNSAdditional Investment in Magnetica
16th Jan 20237:00 amRNSTrading Update, Acquisitions and Notice of Results
23rd Dec 20228:30 amRNSExercise of Options, PDMR Dealings & TVR
14th Dec 20227:00 amRNSSteve McQuillan appointed as Chairman of Adaptix
17th Nov 20223:56 pmRNSResult of Annual General Meeting
28th Sep 20227:00 amRNSPreliminary results for the year ended 31 May 2022
27th Jul 20222:38 pmRNSHolding(s) in Company
7th Jul 20227:00 amRNSTrading Update and Notice of Results
11th Apr 20227:00 amRNSHayward Tyler Secures Nuclear Contracts worth $7m
6th Apr 202212:59 pmRNSExercise of Options and Total Voting Rights
29th Mar 20225:13 pmRNSPDMR Dealing
21st Mar 20227:00 amRNSEnergy Steel Secures Nuclear Contract worth $4.1m
17th Mar 20227:00 amRNSContract Wins
23rd Feb 20227:00 amRNSDirectorate Change
23rd Feb 20227:00 amRNSInterim Results
20th Jan 20227:00 amRNSTrading Update, Notice of Results and Investment
29th Nov 20215:57 pmRNSEmployee & PDMR Share Incentive Awards
22nd Nov 20212:32 pmRNSExercise of Options, PDMR Dealings and TVR
18th Nov 202112:41 pmRNSResult of AGM
13th Oct 20217:00 amRNSInvestment in emerging medtech leader, Adaptix
29th Sep 20217:00 amRNSPreliminary Results for the year ended 31 May 2021
12th Aug 202112:20 pmRNSExercise of Options and Total Voting Rights
12th Jul 202110:51 amRNSExercise of Options, PDMR Dealings and TVR
12th Jul 20217:00 amRNSAvingtrans’ businesses nuclear contract
8th Jul 20217:00 amRNSTrading Update and Notice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.